Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221002785> ?p ?o ?g. }
- W4221002785 endingPage "1121" @default.
- W4221002785 startingPage "1107" @default.
- W4221002785 abstract "Infection by SARS-CoV-2 may elicit uncontrolled and damaging inflammatory responses. Thus, it is critical to identify compounds able to inhibit virus replication and thwart the inflammatory reaction. Here, we show that the plasma levels of the immunoregulatory neuropeptide VIP are elevated in patients with severe COVID-19, correlating with reduced inflammatory mediators and with survival on those patients. In vitro, vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP), highly similar neuropeptides, decreased the SARS-CoV-2 RNA content in human monocytes and viral production in lung epithelial cells, also reducing cell death. Both neuropeptides inhibited the production of proinflammatory mediators in lung epithelial cells and in monocytes. VIP and PACAP prevented in monocytes the SARS-CoV-2-induced activation of NF-kB and SREBP1 and SREBP2, transcriptions factors involved in proinflammatory reactions and lipid metabolism, respectively. They also promoted CREB activation, a transcription factor with antiapoptotic activity and negative regulator of NF-kB. Specific inhibition of NF-kB and SREBP1/2 reproduced the anti-inflammatory, antiviral, and cell death protection effects of VIP and PACAP. Our results support further clinical investigations of these neuropeptides against COVID-19." @default.
- W4221002785 created "2022-04-03" @default.
- W4221002785 creator A5007635891 @default.
- W4221002785 creator A5008262692 @default.
- W4221002785 creator A5010847795 @default.
- W4221002785 creator A5011090397 @default.
- W4221002785 creator A5030482883 @default.
- W4221002785 creator A5033136753 @default.
- W4221002785 creator A5033253153 @default.
- W4221002785 creator A5033779286 @default.
- W4221002785 creator A5041022150 @default.
- W4221002785 creator A5049963014 @default.
- W4221002785 creator A5052393665 @default.
- W4221002785 creator A5059283340 @default.
- W4221002785 creator A5081350037 @default.
- W4221002785 creator A5085955970 @default.
- W4221002785 creator A5086545337 @default.
- W4221002785 creator A5087557108 @default.
- W4221002785 creator A5089439862 @default.
- W4221002785 date "2022-03-24" @default.
- W4221002785 modified "2023-10-18" @default.
- W4221002785 title "VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells" @default.
- W4221002785 cites W1482682744 @default.
- W4221002785 cites W1560545306 @default.
- W4221002785 cites W1577872659 @default.
- W4221002785 cites W1578545218 @default.
- W4221002785 cites W1621058827 @default.
- W4221002785 cites W1774347730 @default.
- W4221002785 cites W1963848904 @default.
- W4221002785 cites W1970452315 @default.
- W4221002785 cites W1970527859 @default.
- W4221002785 cites W1971054351 @default.
- W4221002785 cites W1977286827 @default.
- W4221002785 cites W1984107307 @default.
- W4221002785 cites W1984447869 @default.
- W4221002785 cites W1990360580 @default.
- W4221002785 cites W1991799302 @default.
- W4221002785 cites W2000595900 @default.
- W4221002785 cites W2004153151 @default.
- W4221002785 cites W2014658739 @default.
- W4221002785 cites W2017632365 @default.
- W4221002785 cites W2028612475 @default.
- W4221002785 cites W2033769733 @default.
- W4221002785 cites W2035446086 @default.
- W4221002785 cites W2036257162 @default.
- W4221002785 cites W2045707010 @default.
- W4221002785 cites W2051954356 @default.
- W4221002785 cites W2052893447 @default.
- W4221002785 cites W2056986894 @default.
- W4221002785 cites W2069206441 @default.
- W4221002785 cites W2116186418 @default.
- W4221002785 cites W2118295070 @default.
- W4221002785 cites W2123669249 @default.
- W4221002785 cites W2126124073 @default.
- W4221002785 cites W2128170917 @default.
- W4221002785 cites W2139619692 @default.
- W4221002785 cites W2140820106 @default.
- W4221002785 cites W2148349695 @default.
- W4221002785 cites W2152740168 @default.
- W4221002785 cites W2154166421 @default.
- W4221002785 cites W2156273941 @default.
- W4221002785 cites W2160006107 @default.
- W4221002785 cites W2164161003 @default.
- W4221002785 cites W2167471795 @default.
- W4221002785 cites W2167898988 @default.
- W4221002785 cites W2175952151 @default.
- W4221002785 cites W2190420537 @default.
- W4221002785 cites W2440252045 @default.
- W4221002785 cites W2735527928 @default.
- W4221002785 cites W2752390584 @default.
- W4221002785 cites W2796016575 @default.
- W4221002785 cites W2807588020 @default.
- W4221002785 cites W2908901070 @default.
- W4221002785 cites W2950896857 @default.
- W4221002785 cites W2959234623 @default.
- W4221002785 cites W2995698569 @default.
- W4221002785 cites W3001118548 @default.
- W4221002785 cites W3011610993 @default.
- W4221002785 cites W3011822208 @default.
- W4221002785 cites W3012747666 @default.
- W4221002785 cites W3013231340 @default.
- W4221002785 cites W3014003872 @default.
- W4221002785 cites W3016288338 @default.
- W4221002785 cites W3016489853 @default.
- W4221002785 cites W3023982717 @default.
- W4221002785 cites W3026872319 @default.
- W4221002785 cites W3035895802 @default.
- W4221002785 cites W3036453504 @default.
- W4221002785 cites W3037020655 @default.
- W4221002785 cites W3040801404 @default.
- W4221002785 cites W3048259608 @default.
- W4221002785 cites W3081834127 @default.
- W4221002785 cites W3085958090 @default.
- W4221002785 cites W3086298873 @default.
- W4221002785 cites W3088800697 @default.
- W4221002785 cites W3092135625 @default.
- W4221002785 cites W3093574857 @default.
- W4221002785 cites W3109063130 @default.